Disc Medicine, Inc. (IRON)

Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	91.15	192.43	360.38	194.61	88.04
Short-Term Investments	700.01	297.45	-	-	-
Cash & Short-Term Investments	791.15	489.88	360.38	194.61	88.04
Cash Growth	61.50%	35.93%	85.18%	121.06%	1855.05%
Other Current Assets	12.75	3.73	5.28	3.88	2.45
Total Current Assets	803.9	493.62	365.66	198.49	90.48
Net Property, Plant & Equipment	1.91	2.67	2.1	1.6	1.75
Other Long-Term Assets	0.73	0.84	0.23	0.12	0.18
Total Assets	806.88	496.77	368	200.21	92.41
Accounts Payable	9.02	7.95	12.63	16.16	2.56
Accrued Expenses	27.01	15.24	8.15	6.11	4.1
Current Portion of Leases	0.61	0.13	0.67	0.31	0.32
Total Current Liabilities	36.64	23.32	21.44	22.58	6.97
Long-Term Debt	29.16	28.32	-	-	-
Long-Term Leases	1.25	1.55	1.44	1.03	1.33
Other Long-Term Liabilities	-	-	-	-	6.45
Total Long-Term Liabilities	30.41	29.87	1.44	1.03	7.78
Total Liabilities	67.05	53.19	22.88	23.61	14.76
Common Stock	0	0	0	0	-
Additional Paid-in Capital	1,249	741.3	533.76	288.81	1.19
Accumulated Other Comprehensive Income	0.97	0.29	-	-	-
Retained Earnings	-510.19	-298	-188.65	-112.22	-65.39
Total Common Shareholders' Equity	739.83	443.59	345.12	176.6	-64.2
Minority Interest	-	-	-	-	141.86
Shareholders' Equity	739.83	443.59	345.12	176.6	77.65
Total Liabilities & Equity	806.88	496.77	368	200.21	92.41
Total Debt	31.02	30	2.1	1.33	1.65
Net Cash (Debt)	760.13	459.88	358.28	193.28	86.38
Net Cash Growth	65.29%	28.36%	85.37%	123.74%	-
Net Cash Per Share	21.54	16.66	16.05	185.93	98.34
Book Value	739.83	443.59	345.12	176.6	-64.2
Book Value Per Share	20.96	16.07	15.47	169.89	-73.09
Tangible Book Value	739.83	443.59	345.12	176.6	-64.2
Tangible Book Value Per Share	20.96	16.07	15.47	169.89	-73.09

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q